BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6477350)

  • 1. Antibody-ricin conjugates: a method of linkage which blocks the galactose binding site of ricin.
    Foxwell BM; Ross WC; Thorpe PE
    Behring Inst Mitt; 1984 May; (74):101-7. PubMed ID: 6477350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugates.
    Thorpe PE; Ross WC; Brown AN; Myers CD; Cumber AJ; Foxwell BM; Forrester JT
    Eur J Biochem; 1984 Apr; 140(1):63-71. PubMed ID: 6608447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
    Pietersz GA; Kanellos J; McKenzie IF
    Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.
    Colombatti M; Johnson VG; Skopicki HA; Fendley B; Lewis MS; Youle RJ
    J Immunol; 1987 May; 138(10):3339-44. PubMed ID: 2437188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures.
    Colombatti M; Nabholz M; Gros O; Bron C
    J Immunol; 1983 Dec; 131(6):3091-5. PubMed ID: 6139402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective cytotoxicity of antibody-ricin-A-chain conjugate for human tumor B cells. II. Comparison of activity of immunotoxins conjugated with poly- and monoclonal antibodies].
    Tonevitskiĭ AG; Zhukova OS; Rakhmanova VA; Arsen'eva EL; Bogacheva GT
    Mol Biol (Mosk); 1988; 22(4):911-6. PubMed ID: 3141780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
    Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
    Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.
    Youle RJ; Neville DM
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5483-6. PubMed ID: 6968914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective cytotoxicity of an antibody-ricin A chain conjugate for human tumor cells].
    Tonevitskiĭ AG
    Mol Biol (Mosk); 1985; 19(4):1034-41. PubMed ID: 4047033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-lectin site ricin B chain mutants expressed in insect cells have residual galactose binding: evidence for more than two lectin sites on the ricin toxin B chain.
    Fu T; Burbage C; Tagge E; Chandler J; Willingham M; Frankel A
    Bioconjug Chem; 1996; 7(6):651-8. PubMed ID: 8950484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb.
    Cogliati T; Brusa P; Canevari S; Caldera M; Mezzanzanica D; Dosio F; Cattel L; Colnaghi MI
    Anticancer Res; 1991; 11(1):417-21. PubMed ID: 2018380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.
    Leonard JE; Wang QC; Kaplan NO; Royston I
    Cancer Res; 1985 Nov; 45(11 Pt 1):5263-9. PubMed ID: 3876881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preproricin expressed in Nicotiana tabacum cells in vitro is fully processed and biologically active.
    Tagge EP; Chandler J; Harris B; Czako M; Marton L; Willingham MC; Burbage C; Afrin L; Frankel AE
    Protein Expr Purif; 1996 Aug; 8(1):109-18. PubMed ID: 8812841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of anti-nucleoside-specific antibody production by nucleoside-ricin A conjugate.
    Morimoto C; Masuho Y; Borel Y; Steinberg AD; Schlossman SF
    J Immunol; 1983 Oct; 131(4):1762-4. PubMed ID: 6194214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective cytotoxicity of a ricin A-chain-anti-carcinoembryonic antigen antibody conjugate for a human colon adenocarcinoma cell line.
    Griffin TW; Haynes LR; DeMartino JA
    J Natl Cancer Inst; 1982 Oct; 69(4):799-805. PubMed ID: 6956757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ricin toxin contains at least three galactose-binding sites located in B chain subdomains 1 alpha, 1 beta, and 2 gamma.
    Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham MC
    Biochemistry; 1996 Nov; 35(47):14749-56. PubMed ID: 8942636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow.
    Quinones RR; Youle RJ; Kersey JH; Zanjani ED; Azemove SM; Soderling CC; Lebien TW; Beverley PC; Neville DM; Vallera DA
    J Immunol; 1984 Feb; 132(2):678-83. PubMed ID: 6606676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates.
    Colombatti M; Colombatti A; Blythman HE; Bron C
    J Natl Cancer Inst; 1984 May; 72(5):1095-9. PubMed ID: 6585586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.
    Raso V; Griffin T
    J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.